Overview

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Bepotastine besilate
Ophthalmic Solutions
Pharmaceutical Solutions